U.S. Biotech Stock News

Dover (NYSE:DOV) has been identified as a key beneficiary of growth trends in the global fuel dispenser market. The company is cited for its role in smart fuel dispensing and support for alternative fuels as automation, IoT, and sustainability gain traction. This development highlights longer term opportunities tied to structural shifts in how fuel is monitored, delivered, and managed worldwide. Dover, trading at $223.66, is being noted for its position in fuel dispensing technology at a...

Coca-Cola (NYSE:KO) is discontinuing Minute Maid frozen juice concentrates in the U.S. and Canada after nearly 80 years. The move reflects a shift in its juice portfolio toward ready to drink and refrigerated products. The change affects a long standing grocery staple and may influence how consumers interact with the Minute Maid brand. Coca-Cola, through its Minute Maid brand, has long been a major player in the juice category across frozen, shelf stable, and chilled products. The decision...

Patrick Industries (PATK) capped FY 2025 with Q4 revenue of US$924.2 million and EPS of US$0.90, while trailing twelve month revenue came in at US$4.0 billion and EPS at US$4.16. Over the past few quarters, the company has seen revenue move between US$846.1 million and US$1.05 billion, with quarterly EPS ranging from US$0.45 to US$1.25. This gives investors a clear view of how the top line and per share earnings have tracked into the latest full year run rate. With a trailing net margin of...

Array Digital Infrastructure, Inc. has been monetizing its remaining assets following the past sale of its wireless business to T-Mobile, including distributing a special dividend to shareholders and pursuing additional spectrum sales. An interesting angle is the company’s under-monetized tower portfolio, where recent initiatives have driven rapid cash flow growth and highlighted previously underappreciated asset value. Next, we’ll examine how Array’s ongoing spectrum sales and tower...

Equity Residential (EQR) has wrapped up FY 2025 with fourth quarter revenue of US$781.9 million and basic EPS of US$1.01, alongside funds from operations of US$376.8 million that remain a key gauge for this residential REIT. Over the past few quarters, the company has seen revenue move from US$766.8 million in Q4 2024 to US$781.9 million in Q4 2025. Trailing twelve month basic EPS was US$2.95 and net income reached about US$1.1 billion, which may lead investors to focus on how margins and...

New Chief Product Officer puts AI focus in the spotlight CCC Intelligent Solutions Holdings (CCC) has appointed Josh Valdez as Chief Product Officer, with a mandate to oversee product strategy, design, and delivery, including scaling AI-driven capabilities across its insurance-focused SaaS platform. See our latest analysis for CCC Intelligent Solutions Holdings. Despite the appointment of a new Chief Product Officer and recent updates such as the upcoming Q4 2025 results release and workforce...

Liberty Live Holdings, Inc. came under pressure after Live Nation’s past third‑quarter earnings showed weaker‑than‑expected concert segment results and management reduced its 2026 ticketing outlook due to regulatory actions on ticket bots and costs tied to an FTC lawsuit. The episode highlights how Liberty Live’s exposure to Live Nation links its investment story not just to concert demand, but also to evolving regulatory and legal risks around ticketing. Next, we will consider how Live...

AI report puts DigitalOcean Holdings (DOCN) in focus DigitalOcean Holdings (DOCN) is back on investors’ radar after its latest Currents report highlighted how more businesses now treat AI as a core strategy and are reallocating spend from training to inference. The company also pointed to rising demand for integrated AI infrastructure and platform tools, which puts extra attention on how its cloud offering lines up against these usage trends and what that might mean for its business mix. See...

McCormick stock: what the recent performance tells you McCormick (MKC) has drawn fresh attention after a recent stretch of mixed returns, with the share price roughly flat year to date, modest gains over the past 3 months, and a 1 year total return decline. For investors, that combination of muted near term moves and weaker 1 year performance raises a simple question: does the current price around $67.42 fairly reflect a business generating US$6.84b in revenue and US$789.4m in net income, or...

Figma (NYSE:FIG) reports accelerating revenue growth and deeper customer spend, with large-customer revenues and annual revenue run rate reaching record levels. The company expands its AI focus through the acquisition of an AI-focused startup, reinforcing its product roadmap around AI driven design capabilities. These business updates arrive after recent analyst downgrades and a sharp share price pullback, drawing attention to fundamentals rather than sentiment. Figma sits at the center of...

Otis Worldwide (OTIS) is back in focus after its latest quarterly report delivered year-on-year revenue and profit growth but fell short of Wall Street revenue forecasts, particularly in new equipment and repair driven service. See our latest analysis for Otis Worldwide. The stock has been choppy around its latest earnings and dividend declaration, with a 5.19% 7 day share price return but a 3.56% decline in 1 year total shareholder return, so recent momentum contrasts with more muted longer...

First BanCorp (FBP) is drawing investor attention after recent trading, with the stock closing at $23.22 and showing positive returns over the past month and past 3 months. That move is prompting a closer look. See our latest analysis for First BanCorp. The recent 1 month share price return of 10.0% and 3 month share price return of 16.0% build on a year to date share price return of 11.1%. The 5 year total shareholder return of 171.5% shows how long term holders have been rewarded. If this...

Arrowhead Pharmaceuticals (ARWR) has opened fiscal 2026 with Q1 revenue of US$264.0 million and basic EPS of US$0.22, supported by net income of US$30.8 million as the company continues to build on its move into profitability over the past year. Over recent quarters, revenue has shifted from US$2.5 million in Q1 2025 to US$542.7 million in Q2 2025, US$27.8 million in Q3 2025, US$256.5 million in Q4 2025, and now US$264.0 million in Q1 2026. EPS has moved from a loss of US$1.39 per share in Q1...

Recent commentary on Henry Schein highlights that its organic revenue growth has lagged industry benchmarks over the past two years, while returns on capital have also contracted, suggesting rising competitive pressures on its core distribution business. These trends raise questions about whether Henry Schein’s existing product mix, pricing, and go-to-market approach remain sufficient to defend its position in increasingly contested healthcare markets. Against this backdrop, we will examine...

In early February 2026, DocuSign came under pressure as part of a broader software sector sell-off tied to concerns about artificial intelligence reshaping specialized software markets. The release of Anthropic’s AI-powered legal automation tools intensified worries that new AI capabilities could encroach on DocuSign’s core workflows and weaken traditional SaaS models. We’ll now look at how these AI disruption fears, particularly around Anthropic’s legal tools, may influence DocuSign’s...

Digital Realty Trust (DLR) closed out FY 2025 with Q4 revenue of US$1.6b and basic EPS of US$0.26, while funds from operations reached US$657.9m, giving investors a clear read on both top line scale and REIT specific cash generation. Over the last few quarters, the company has seen revenue move from US$1.40b in Q4 2024 to US$1.64b in Q3 2025 and then to US$1.64b in Q4 2025, with basic EPS ranging from US$0.54 in Q4 2024 to US$0.17 in Q3 2025 and US$0.26 in Q4 2025. With trailing twelve month...

Guardant Health (NasdaqGS:GH) reported results from a landmark study of its Guardant Reveal liquid biopsy test for minimal residual disease in resected stage III colon cancer. The study, conducted with Mayo Clinic and the Alliance for Clinical Trials in Oncology, is described as the largest published analysis of circulating tumor DNA in this setting. Published in the Journal of Clinical Oncology, the data indicate that Guardant Reveal more accurately predicts recurrence and survival than...

Rambus Inc. has reported past fourth-quarter 2025 results showing revenue of US$190.24 million and net income of US$63.84 million, alongside full-year 2025 revenue of US$707.63 million and net income of US$230.46 million. The company also issued first-quarter 2026 guidance that breaks out expected licensing, royalty, product, and contract revenues, offering investors a detailed look at its anticipated revenue mix. With this fresh earnings report and granular revenue guidance, we’ll now...

Why the latest earnings and analyst update matter for Eagle Materials (EXP) Eagle Materials (EXP) reported third quarter results showing lower net income and earnings per share compared with a year earlier, while a well followed analyst trimmed their outlook and prompted investors to reassess the stock’s risk reward profile. See our latest analysis for Eagle Materials. Despite softer quarterly earnings and a more cautious analyst stance, Eagle Materials’ recent share price performance has...

Banc of California, Inc. recently declared a quarterly common stock dividend of US$0.12 per share, a 20% increase, and reaffirmed a quarterly US$0.4845 per depositary share dividend on its 7.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series F, payable in March and April 2026 to holders of record on the specified dates. This combination of a higher common dividend and continued preferred payouts highlights the bank’s current emphasis on returning cash to shareholders through...

In late January 2026, Stride, Inc. reported past second-quarter results showing higher sales of US$631.26 million and increased net income of US$99.48 million, while also issuing third-quarter revenue guidance of US$615 million to US$645 million and full-year 2026 revenue guidance of US$2.48 billion to US$2.56 billion. Management highlighted that strong enrollment and revenue growth in the Career Learning segment, alongside reaffirmed full-year revenue guidance and a higher adjusted...

Centene (CNC) just closed out FY 2025 with Q4 revenue of US$45.1b and a basic EPS loss of US$2.24, capping a trailing twelve month period where revenue reached US$176.2b and basic EPS stood at a loss of US$13.53. The company has seen quarterly revenue move from US$36.6b in Q4 2024 and US$37.3b in Q3 2024 to the current US$45.1b and US$45.3b in Q4 and Q3 2025. Over the same periods, EPS shifted from US$0.57 and US$1.37 in those 2024 quarters to losses of US$2.24 and US$13.50 in the latest 2025...

WEC Energy Group (WEC) closed out FY 2025 with fourth quarter revenue of US$2.5b and basic EPS of US$0.97, supported by net income of US$316.6m. The trailing twelve months show revenue of US$9.8b and EPS of US$4.84 on net income of US$1.56b. Over the past few quarters, the company has reported revenue in a range from US$2.0b to US$3.1b, and quarterly EPS between US$0.77 and US$2.28. Trailing twelve month revenue increased from US$8.6b in late 2024 to US$9.8b in late 2025. Taken together, the...

UnitedHealth Group (UNH) is back in focus after its stock sold off sharply on worries about minimal proposed increases in Medicare Advantage rates, rising medical costs, softer 2026 revenue guidance, and restructuring related pressures. See our latest analysis for UnitedHealth Group. At a share price of US$276.65, UnitedHealth Group has seen a 19.04% 1 month share price decline and a 46.22% 1 year total shareholder return loss. The 1 day share price gain of 3.02% hints at sentiment trying to...